KEVIN TAHERI

PERRY ABADIR

DR. ROBERT FOSTER

DAVID MATLOFF

DANNY D’ULL

Management Team

Dr. Robert Foster
Chief Science Officer

Dr. Robert Foster co-founded Renasci Inc. in 2000 with the express intent of changing the face of healthcare in the United States. Rather than accept the fact that the physical and mental effects of aging and other chronic physiological conditions are irreversible and unchangeable, Renasci launched a new era in the understanding and treatment of the issues of tissue regeneration and repair. Since 2000, Dr. Foster has collaborated with a number of companies in an effort to create new diagnostics and procedures for rapid, convenient and cost effective assessment of the body’s physiological state and support for tissue regeneration. These efforts have resulted in the creation of Molecular Regenix LLC, a joint collaboration with CoValence Inc., a major skincare product manufacturer. Molecular Regenix has developed a line of supplements based on state-of-the-art natural biochemistry to support the creation of lean body mass, cardiovascular health, exercise recovery, skin protection, joint health and wound healing. In addition, MR has a novel wound healing topical formulation based on natural biochemistry in clinical trials that will conclude in Q1 2006. All these products and formulations are protected by patents and are directed toward tissue regeneration and addressing areas of major concern such as chronic inflammation. The goal of this work is to give all people a simple set of products that can control the processes of degradation caused by aging and other chronic conditions and to help prevent these processes from occurring at all.

Prior to the founding of Renasci, Dr. Foster worked for more that 20 years in the high tech business of Semiconductor Capital Equipment. He held various positions from process development to upper management. In 1996 Dr. Foster became the CEO of Materials Research Corporation (MRC), a wholly owned subsidiary of Sony Corporation. Dr. Foster led a team of experienced managers and technologists that engineered a complete turn-around of MRC from major losses to profitability. This reversal of fortunes not only was the result of increased efficiency but also the creation of new, innovative technologies that are in use today in many advanced computer chips. In 1998, Dr. Foster led his team in the sale of MRC to a multi-national equipment manufacturer, Tokyo Electron Limited (TEL). Dr. Foster remained at TEL for 2 years as the President of the local subsidiary Tokyo Electron Arizona. After the business and technology integration was complete in 2000, Dr. Foster left TEL to pursue his dream of molecular discovery to help the body heal itself by regeneration and to fight the degradation of chronic conditions such as aging.

Dr. Foster received a PhD in chemistry from Harvard University and was a National Science Foundation Post-Doctoral Fellow at Stanford University. The nature of this work has been to elucidate fundamental feature of chemical reaction mechanisms from simple rearrangement to ionic reactions that can be applied to more complex systems. Most recently Dr. Foster has worked on novel chemical supplements for the body and the use of nanotechnology for wound healing and other anti-inflammatory applications. However, he spends most of his time trying to keep up with three daughters, Maya, Carine and Juliette, who teach him more than any scientific paper can ever contemplate.